Intensity modulated radiation therapy (IMRT) for the treatment of unicentric Castlemans disease: A case report and review of the use of radiotherapy in the literature

Radiology and Oncology

Volumn 46, Issue 3, 2012, Pages 265-270

  Matthiesen, Chance ^a   Ramgopol, Rajeev ^a   Seavey, Jonathan ^a   Ahmad, Salahuddin ^a   Herman, Terence ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Castleman's disease; IMRT

Indexed keywords

CORTICOSTEROID;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOGRAM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INJURY; INTENSITY MODULATED RADIATION THERAPY; LUNG BIOPSY; MEDIASTINOSCOPY; MEDIASTINUM MASS; RADIATION DOSE; RADIATION EQUIPMENT; RADIATION PNEUMONIA; TRAFFIC ACCIDENT; TREATMENT DURATION; TREATMENT PLANNING; TUMOR BIOPSY; UNICENTRIC CASTLEMAN DISEASE;

EID: 84867283204     PISSN: 13182099     EISSN: 15813207     Source Type: Journal    
DOI: 10.2478/v10019-012-0008-0     Document Type: Article

References (32)

1. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer 1956; 9: 822-30.
2. Gaba AR, Stein RS, Sweet DL, Variakojis D. Multicentric giant lymph node hyperplasia. Am J Clin Pathol 1978; 69: 86-90. (Pubitemid 8269654)
3. Soulier J, Grollet L, Oksenhendler E, Miclea JM, Cacoub P, Baruchel A, et al. Molecular analysis of clonality in Castleman's disease. Blood 1995; 86: 1131-8.
4. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995; 86: 1276-80.
5. Gessain A, Sudaka A, Brière J, Fouchard N, Nicola MA, Rio B, et al. Kaposi sarcoma-associated herpes-like virus (human herpesvirus type 8) DNA sequences in multicentric Castleman's disease: is there any relevant association in non-human immunodeficiency virus-infected patients? Blood 1996; 87: 414-6. (Pubitemid 26011859)
6. Herrada J, Cabanillas F, Rice L, Manning J, Pugh W. The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med 1998; 128: 657-62. (Pubitemid 28169643)
7. Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. Br J Haematol 2005; 129: 3-17. (Pubitemid 40524047)
8. Seco JL, Velasco F, Manuel JS, Serrano SR, Tomas L, Velasco A. Retroperitoneal Castleman's disease. Surgery 1992; 112: 850-5.
9. McCarty MJ, Vukelja SJ, Banks PM, Weiss RB. Angiofollicular lymph node hyperplasia (Castleman's disease). Cancer Treat Rev 1995; 21: 291-310.
10. Shahidi H, Myers JL, Kvale PA. Castleman's disease. Mayo Clin Proc 1995; 70: 969-77.
11. Neuhof D, Debus J. Outcome and late complications of radiotherapy in patients with unicentric Castleman disease. Acta Oncol 2006; 45: 1126-31. (Pubitemid 44808501)
12. Chronowski GM, Ha CS, Wilder RB, Cabanillas F, Manning J, Cox JD. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer 2001; 92: 670-6. (Pubitemid 32735205)
13. Bowne WB, Lewis JJ, Filippa DA, Niesvizky R, Brooks AD, Burt ME, et al. The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature. Cancer 1999; 85: 706-17. (Pubitemid 29075292)
14. de Vries IA, van Acht MM, Demeyere TB, Lybeert ML, de Zoete JP, Nieuwenhuijzen GA. Neoadjuvant radiotherapy of primary irresectable unicentric Castleman's disease: a case report and review of the literature. Radiat Oncol 2010; 5: 7.
15. Peterson BA, Frizzera G. Multicentric Castleman's disease. Semin Oncol 1993; 20: 636-47. (Pubitemid 24015203)
16. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972; 29: 670-83.
17. Ye B, Gao SG, Li W, Yang LH, Zhao SH, Ma K, et al. A retrospective study of unicentric and multicentric Castleman's disease: a report of 52 patients. Med Oncol 2010; 27: 1171-8.
18. Lin CY, Chang YL. Castleman's disease in the head and neck region: Metaanalysis of reported cases in Taiwan and literature review. J Formos Med Assoc 2010; 109: 913-20.
19. Paumier A, Ghalibafian M, Beaudre A, Ferreira I, Pichenot C, Messai T, et al. Involved-node radiotherapy and modern radiation treatment techniques in patients with Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 2011; 80: 199-205.
20. Welsh J, Gomez D, Palmer MB, Riley BA, Mayankkumar AV, Komaki R, Dong L, et al. Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: A dosimetric study. Int J Radiat Oncol Biol Phys 2011; 81: 1336-42.
21. Lievens Y, Nulens A, Gaber MA, Defraene G, De Wever W, Stroobants S, et al. Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning study. Int J Radiat Oncol Biol Phys 2011; 80: 306-13.
22. Banu A, Enis O, Kaan G, Gungor G. Intensity modulated radiotherapy (IMRT) in bilateral retinoblastoma. Radiol Oncol 2010; 44: 194-8.
23. Bailey DW, Lalith K; Podgorsak MB. A fully electronic intensity-modulated radiation therapy quality assurance (IMRT) process implemented in a network comprised of independent treatment planning, record and verify, and delivery systems. Radiol Oncol 2010; 44: 124-30.
24. Ladowska A, Hetnał M, Dymek P, Kabat D, Kisielewicz K, Wawrzak M, et al. Application of IMRT in adjuvant treatment of soft tissue sarcomas of the thigh-preliminary results. Reports of Practical Oncology and Radiotherapy 2011; 16: 110-4.
25. Weisenburger DD, DeGowin RL, Gibson P, Armitage JO. Remission of giant lymph node hyperplasia with anemia after radiotherapy. Cancer 1979; 44: 457-62. (Pubitemid 10220127)
26. Nordstrom DG, Tewfik HH, Latourette HB. Plasma cell giant lymph node hyperplasia responding to radiation therapy. AJR Am J Roentgenol 1978; 130: 169-71. (Pubitemid 8259606)
27. Marti S, Pahissa A, Guardia J, Moragas A, Bacardi R. Multicentric giant follicular lymph node hyperplasia. Favorable response to radiotherapy. Cancer 1983; 51: 808-10. (Pubitemid 13143155)
28. Veldhuis GJ, van der Leest AH, de Wolf JT, de Vries EG, Vellenga E. A case of localized Castleman's disease with systemic involvement: treatment and pathogenetic aspects. Ann Hematol 1996; 73: 47-50. (Pubitemid 26254235)
29. Beck JT, Hsu SM, Wijdenes J, Bataille R, Klein B, Vesole D, et al. Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. N Engl J Med 1994; 330: 602-5. (Pubitemid 24065794)
30. Li X, Wang X, Li Y, Zhang X. A 4D IMRT planning method using deformable image registration to improve normal tissue sparing with contemporary delivery techniques. Radiat Oncol 2011; 6: 83.
31. Chapet O, Fraass BA, Ten Haken RK. Multiple fields may offer better esophagus sparing without increased probability of lung toxicity in optimized IMRT of lung tumors. Int J Radiat Oncol Biol Phys 2006; 65: 255-65.
32. Suciu D. Cellular death by apoptosis in some radiosensitive and radioresistant mammalian tissues. J Theor Biol 1983; 105: 391-401. (Pubitemid 14213367)